GRAB SOME...

RSI(14) Oversold
Stochastic(14) Oversold

XN intends to declare a yearly dividend with a target payout ratio of between 30%-50% of its profit attributable to its owners on a consolidated basis.

Maybank Investment Bank Bhd is the principal adviser, joint global coordinator, joint bookrunner, joint managing underwriter and joint underwriter for the IPO. CIMB Investment Bank Bhd is the joint global coordinator, joint bookrunner, joint managing underwriter and joint underwriter for the IPO.

We will continue to focus on delivering health-oriented and wellness consumer products to our customers around the world and provide returns to our shareholders in accordance with our target payout ratio of between 30%-50% of the profit attributable to the owners of DXN for each financial year on a consolidated basis,” Lim said.

DXN is planning to expand its business operations to five new markets within the next three to five years.

Lim stated that these five countries, located in Latin America and Africa, are Brazil, Argentina, Ghana, Niger , and Algeria.

“Our new branches in Brazil and Argentina are expected to be operational by the end of this year, while the other three countries within the next two to three years. We anticipate that it will take between three to five years to fully develop the potential in these five new markets. During that time, we hope to be fully prepared to enter the Chinese market as well,” he said.

Previously listed on the Main Market in 2003, it was delisted in December 2011 for the purpose of restructuring the company’s operations. Since privatisation, its revenue growth accelerated with a compound annual growth rate (CAGR) of 17.2%.

at 10sen, market cap only rm60MIL+ TOO SMALL. UNDERVALUE

rebound is inevitable.... stay calm...

DXN Holdings Bhd
DXN Holdings Bhd. is an investment holding company. The Company, through its subsidiaries, manufactures and markets health food and dietary supplements, food and beverages, personal care products, skin care and cosmetics, household products, and water treatment system. DXN Holdings serves customers worldwide.

In 2018, DXN was listed 15th on the Direct Selling News Global 100 list of direct selling companies

"Malaysia's DXN mulling aggressive marketing plan in Sri Lanka". Daily News. January 5, 2017. Retrieved November 28, 2018.
Daxen 2005 Financial Statement
"DXN Europe Branches and Service Centers". Retrieved November 28, 2018.
"Contact Us". DXN Asia. Retrieved November 28, 2018.
KLSE Info, http://www.klse.info/counters/announcements/stock/ Archived 2013-02-18 at archive.today
"DXN disposes entire stake in Daxen Biotech". Daily Express. March 1, 2011. Retrieved November 28, 2018.
"DSN Announces the 2019 Global 100! - Direct Selling News".

DXN Holdings Berhad was first listed on the main board of Bursa Malaysia in September 2003 and delisted in December 2011 following a takeover bid by the founder.citation needed] DXN Holdings was the sole shareholder of Daxen Biotechnology, a Malaysia-based manufacturer of monascus, vinegar, fruit enzymes and other beverage products.

DXN manufactures and markets dietary supplements containing the mushrooms Ganoderma or Lingzhi. DXN products are marketed by affiliated companies Daehsan, Ltd. and Daxen in some countries in Europe and Asia.

Which is the world's largest Ganoderma company?
DXN Asia Official Site
DXN
With over 14.9 million registered distributors worldwide, DXN is solidifying its position as one of the world leader in Ganoderma products.

DXN Asia Official Site

Dxn is world leader in Ganoderma products.

~180 mil shares dah bertukar tangan.... terindah

the founders of DXN, mau jaga face, rebound dah pasti :)

recovery... love it... above 70sen before 5pm is ON show

above 70sen sebelum 5pm, semoga berjaya

diramalkan ia akan terbang dengan mengejut.... wait n see

baru 10am, 125mil shares+++ pembeli grab dari penakut retailer

125mil shares++ dah sapu

tengok reaksi nanti

ride on it....

dah berpakat dah, kena rendah pd permulaan, nanti kasi terbang nonstop

retailers yg penakut rugi, pembeli kini untung

beli sekarang untung dari retailer IPO

mau trick retailers jualkan dulu, then beli secara nonstop dengan gila... accumulate awal

IPO price 70sen, below 70sen, grab ya... growing like crazy.... terbukti

The relisting of the health and wellness products maker’s IPO will involve the sale of 932.7 million ordinary shares in DXN, comprising 772.7 million existing shares and a public issue of 160 million new shares.

ada gang mau play game dulu... nanti naik / terbang gila.... sabar ya

less than 1bil shares for the public and institution investors.... nanti, strong surge... be patient

stay invested... the time to accumulate is now :)

History
Date Price Change Dir-Volume Day Volume Dir-Value Day Value Avg Price % of Total Share Remarks
01/06/2021 00:00:00 0.2150 0.0250 500,000 500,000 107,500 107,500 0.2150 0.0760 -
30/08/2018 00:00:00 0.1300 - 100,000 100,000 13,000 13,000 0.1300 0.0152 -
30/03/2018 00:00:00 0.1500 0.0100 100,000 100,000 15,000 15,000 0.1500 0.0152 -
21/07/2017 00:00:00 0.1600 - 234,650 469,300 37,544 75,088 0.1600 0.0357 -
21/07/2017 00:00:00 0.1600 - 234,650 469,300 37,544 75,088 0.1600 0.0357 -
16/11/2015 00:00:00 0.2000 - 1.800m 1.800m 360,000 360,000 0.2000 0.2736 -
29/10/2015 00:00:00 0.2000 - 4.950m 4.950m 990,000 990,000 0.2000 0.7523 -
25/08/2015 00:00:00 0.2100 0.0150 1.000m 1.000m 210,000 210,000 0.2100 0.1520 -

growing miraculously... post-pandemic more rigorously
In a Bursa Malaysia filing on Tuesday (May 16), DXN said revenue for the quarter rose 19.3% to RM404.5 million from RM339.35 million a year ago.

69 to 70,5sen+++++++++++++, expecting 75 to 80sen at closing

buy rate above 55%

sudden surge anytime... grab some

tahun ni, tahun pemulihan bagi picorp..... tiada halangan untuk menjalankan fieldwork, dll

just stay invested... macam robo advisor, auto pilot selepas membelinya

kalau shariah funds mgr belinya, 20sen+ pun senang capai

tiada yg mustahil... picorp bukan sebarang

@fregend

0.12 boleh kah Picorp before AGM

7 minutes ago

Date Open High Low Close Change Volume
2023-05-15 0.10 0.105 0.10 0.105 +0.005 (5.00%) 7,652,700
2023-05-12 0.10 0.10 0.095 0.10 0.00 (0.00%) 323,600
2023-05-11 0.095 0.10 0.095 0.10 0.00 (0.00%) 1,162,700

Price Target
A price target is an analyst's projection of a share's future price.

Average Target Price, Price Call and Upside/Downside here are derived from Price Targets in the past 6 months.

Last Price

0.105

Avg Target Price

0.28

Upside/Downside

+0.175 (166.67%)


https://klse.i3investor.com/web/stock/analysis-price-target/7201

say market cap should be RM100mil, total shares issued 658mil, price per share should be 100/658=15sen++ , if RM200mil, =30sen++

sabar bro!

bagi mereka yg dah penat dengan kripto, ace market stok, robo advisor, dll, masa terbaik untuk melabur dlm picorp, ESG biz stok, main board, shariah compliant :)

Cost averaging approach beli from time to time continuously

Perfect skor bagi buy rate 100% kini terindah

Pulangan nanti dijangka jauh lebih lumayan daripada robo advisor, emas, asb, dll

Mereka yang nampak potensinya sanggup mengumpul syernya secara berterusan

Usah terkejut bila harga syer picorp sudden jump beberapa sen

Subsi picorp di Indonesia juga boleh fokus pada Kalimantan, ibukota terbaru Indonesia, nusantara akan dibina di pulau tersebut...

Picorp, main board, shariah compliant, shariah funds dari dalam dan luar negara juga boleh membeli syernya

Selepas pandemik, servis picorp dah balik expansion mode... Peluang tak terhingga

Juga ada kemungkinan bahawa pemegang syer kedua terbesar di Singapore sedang menambah stakenya... While the share price is low... :)